Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01826487 |
|---|---|
| Brief Title: | Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) (ACT DMD) |
| First Submitted : | March 26, 2013 |
| First Submitted that Met QC Criteria : | April 3, 2013 |
| First Posted : | April 8, 2013 (Estimate) |
| Results First Submitted : | July 17, 2020 |
| Results First Submitted that Met QC Criteria : | July 17, 2020 |
| Results First Posted : | August 4, 2020 |
| Certification/Extension First Submitted : | April 1, 2019 |
| Certification/Extension First Submitted that Met QC Criteria : | April 1, 2019 |
| Certification/Extension First Posted : | April 8, 2019 |
| Last Update Submitted that Met QC Criteria : | July 17, 2020 |
| Last Update Posted : | August 4, 2020 |